Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

Lisa C. Holthof, Hilma J. van der Horst, Susan E. van Hal-van Veen, Ruud W.J. Ruiter, Fengzhi Li, Marijke Buijze, Morten N. Andersen, Huipin Yuan, Joost de Bruijn, Niels W.C.J. van de Donk, Henk M. Lokhorst, Sonja Zweegman, Richard W.J. Groen, Tuna Mutis

Research output: Contribution to journalLetterAcademicpeer-review

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)e80-e83
Issue number2
Early online date23 May 2019
Publication statusPublished - 31 Jan 2020

Cite this